Walgreens Boots Alliance (NASDAQ:WBA) Issues Quarterly Earnings Results, Beats Expectations By $0.30 EPS

Walgreens Boots Alliance (NASDAQ:WBA) announced its earnings results on Tuesday. The pharmacy operator reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.30, MarketWatch Earnings reports. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The business had revenue of $32.78 billion during the quarter, compared to analyst estimates of $36.16 billion. During the same period in the previous year, the business earned $1.52 EPS. The company’s quarterly revenue was down 8.5% compared to the same quarter last year.

NASDAQ WBA traded down $0.60 during trading on Thursday, hitting $54.30. 187,290 shares of the stock traded hands, compared to its average volume of 6,665,064. The company has a market capitalization of $46.92 billion, a P/E ratio of 107.94, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. Walgreens Boots Alliance has a 12-month low of $33.36 and a 12-month high of $56.78. The firm has a 50-day simple moving average of $50.41 and a 200-day simple moving average of $43.08. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 12th. Stockholders of record on Friday, February 19th were given a dividend of $0.4675 per share. The ex-dividend date of this dividend was Thursday, February 18th. This represents a $1.87 dividend on an annualized basis and a dividend yield of 3.44%. Walgreens Boots Alliance’s payout ratio is 39.45%.

Several research analysts have issued reports on WBA shares. Mizuho raised their target price on Walgreens Boots Alliance from $37.00 to $47.00 and gave the stock a “neutral” rating in a research report on Monday, January 11th. Truist boosted their target price on shares of Walgreens Boots Alliance from $44.00 to $48.00 in a research report on Friday, January 8th. Morgan Stanley increased their price target on shares of Walgreens Boots Alliance from $40.00 to $52.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Barclays lifted their price target on shares of Walgreens Boots Alliance from $40.00 to $47.00 and gave the stock an “equal weight” rating in a research note on Friday, January 8th. Finally, Robert W. Baird upgraded Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and upped their price objective for the stock from $41.00 to $55.00 in a research note on Monday, January 11th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $45.78.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Story: Moving Average (MA)

Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.